BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11105029)

  • 1. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs.
    Schnorr J; Wagner S; Abramjuk C; Wojner I; Schink T; Kroencke TJ; Schellenberger E; Hamm B; Pilgrimm H; Taupitz M
    Invest Radiol; 2004 Sep; 39(9):546-53. PubMed ID: 15308937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related blood half-life of particulate contrast material: experimental results with a USPIO in rats.
    Schnorr J; Taupitz M; Wagner S; Pilgrimm H; Hansel J; Hamm B
    J Magn Reson Imaging; 2000 Nov; 12(5):740-4. PubMed ID: 11050644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.
    Schnorr J; Taupitz M; Schellenberger EA; Warmuth C; Fahlenkamp UL; Wagner S; Kaufels N; Wagner M
    Rofo; 2012 Feb; 184(2):105-12. PubMed ID: 22179768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization.
    Wagner S; Schnorr J; Pilgrimm H; Hamm B; Taupitz M
    Invest Radiol; 2002 Apr; 37(4):167-77. PubMed ID: 11923639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium.
    Taupitz M; Schnorr J; Wagner S; Abramjuk C; Pilgrimm H; Kivelitz D; Schink T; Hansel J; Laub G; Hünigen H; Hamm B
    Radiology; 2002 Jan; 222(1):120-6. PubMed ID: 11756715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits.
    Loubeyre P; Zhao S; Canet E; Abidi H; Benderbous S; Revel D
    J Magn Reson Imaging; 1997; 7(6):958-62. PubMed ID: 9400837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans.
    Wagner M; Wagner S; Schnorr J; Schellenberger E; Kivelitz D; Krug L; Dewey M; Laule M; Hamm B; Taupitz M
    J Magn Reson Imaging; 2011 Oct; 34(4):816-23. PubMed ID: 21769977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C; Allkemper T; Baermig J; Reimer P
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hemorrhage: imaging with a new magnetic resonance blood pool agent in conjunction with breathheld three-dimensional magnetic resonance angiography.
    Weishaupt D; Hilfiker PR; Schmidt M; Debatin JF
    Cardiovasc Intervent Radiol; 1999; 22(4):321-5. PubMed ID: 10415223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced 3D-MRA of the upper abdomen with a bolus-injectable SPIO (SH U 555 A).
    Reimer P; Allkemper T; Matuszewski L; Balzer T
    J Magn Reson Imaging; 1999 Jul; 10(1):65-71. PubMed ID: 10398979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.
    Clarke SE; Weinmann HJ; Dai E; Lucas AR; Rutt BK
    Radiology; 2000 Mar; 214(3):787-94. PubMed ID: 10715047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent.
    Li W; Tutton S; Vu AT; Pierchala L; Li BS; Lewis JM; Prasad PV; Edelman RR
    J Magn Reson Imaging; 2005 Jan; 21(1):46-52. PubMed ID: 15611942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
    Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
    Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPIO-enhanced 2D-TOF MR angiography of the portal venous system: results of an intraindividual comparison.
    Reimer P; Marx C; Rummeny EJ; Müller M; Lentschig M; Balzer T; Dietl KH; Sulkowski U; Berns T; Shamsi K; Peters PE
    J Magn Reson Imaging; 1997; 7(6):945-9. PubMed ID: 9400835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study.
    Tombach B; Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Heindel W
    NMR Biomed; 2004 Nov; 17(7):500-6. PubMed ID: 15523717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-of-flight MR angiography with Gd-DTPA hexamethylene diamine co-polymer blood pool contrast agent: comparison of enhanced MRA and conventional angiography for arterial stenosis induced in rabbits.
    Bonk RT; Schmiedl UP; Yuan C; Nelson JA; Black CD; Ladd DL
    J Magn Reson Imaging; 2000 Jun; 11(6):638-46. PubMed ID: 10862063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced 3D-TOF MRA of peripheral vessels: intravascular versus extracellular MR contrast media.
    Engelbrecht MR; Saeed M; Wendland MF; Canet E; Oksendal AN; Higgins CB
    J Magn Reson Imaging; 1998; 8(3):616-21. PubMed ID: 9626876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.